Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis and pregnancy].

S Vukusic1, C Confavreux

  • 1Service de Neurologie A, Hôpital Neurologique Pierre Wertheimer, 59, boulevard Pinel, 69677 Bron Cedex. sandra.vukusic@chu-lyon.fr

Revue Neurologique
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Target trial emulation for causal inference using observational data in neurology.

Revue neurologique·2026
Same author

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Big multiple sclerosis data network: novel modelling approaches for real-world data analysis.

Journal of neurology·2025
Same author

French guidelines for the diagnosis and management of MOG antibody-associated disease.

Revue neurologique·2025
Same author

Data linkage between the French multiple sclerosis cohort (OFSEP) and the French national health insurance database (SNDS).

Revue neurologique·2025
Same author

Multiple sclerosis and epilepsy.

Revue neurologique·2025
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Pregnancy temporarily reduces multiple sclerosis (MS) relapses, but a post-partum increase occurs. The PRIMS study informed new strategies targeting hormonal influences on MS during and after pregnancy.

Area of Science:

  • Neurology
  • Immunology
  • Reproductive Medicine

Background:

  • Pregnancy's impact on multiple sclerosis (MS) course has been debated, historically discouraging women with MS from childbearing.
  • The Pregnancy in Multiple Sclerosis (PRIMS) study aimed to prospectively evaluate pregnancy's influence on MS clinical activity.

Purpose of the Study:

  • To assess the effect of pregnancy and delivery on the clinical course of multiple sclerosis (MS).
  • To identify predictors of post-partum relapses in women with MS.
  • To inform therapeutic strategies for managing MS during and after pregnancy.

Main Methods:

  • Prospective cohort study including 254 women diagnosed with MS during pregnancy.
  • Follow-up until two years post-partum.
  • Logistic regression analysis to identify relapse predictors.

Related Experiment Videos

Main Results:

  • A decreased MS relapse rate during pregnancy, particularly in the third trimester, compared to the year prior.
  • A significant increase in relapse rate during the first trimester post-partum, returning to pre-pregnancy levels by the second trimester.
  • Approximately one-third of women experienced a post-partum relapse; pregnancy did not affect long-term disability progression.

Conclusions:

  • Pregnancy modifies MS activity, with a notable post-partum relapse risk.
  • Disease activity prior to and during pregnancy predicts post-partum relapses.
  • Findings support therapeutic strategies targeting hormonal influences for preventing post-partum MS relapses, with ongoing trials investigating hormone therapy.